Financials & Reports

Explore key financial metrics, condensed statements and narrative analysis from Laurel Ridge Health’s FY 2024 Annual Financial Report. The data below (rounded to the nearest thousand dollars) provides a starting point for deeper case exercises.

Financial charts with medical professionals analysing data

Financial highlights

Total revenue (FY2024)
$713M
Driven by higher patient volumes and expanded services
Net income (FY2024)
$34.4M
Including investment income and contributions
Operating margin
2.1%
Peer median 3.0%
Net margin
4.4%
Peer median 4.5%
Days cash on hand
95
Peer median 180 days
Debt‑to‑equity
0.70
Peer median 0.55
Accounts receivable days
57
Peer median 48

These metrics highlight a system under some financial strain—particularly in liquidity—but still generating positive margins supported by non‑operating income. Use them as benchmarks to explore how changes in payer mix, expenses or investment returns would affect performance.

Condensed balance sheet

The balance sheet (or statement of financial position) summarizes assets, liabilities and net assets at year end. Laurel Ridge saw significant growth in its asset base in FY 2024, financed primarily through increased long‑term debt.

Assets FY2024 ($000s) FY2023 ($000s)
Cash & Cash Equivalents 122,140 110,000
Short‑term Investments 48,000 53,000
Net Patient Accounts Receivable 147,000 112,000
Inventories 21,250 16,500
Total Current Assets 338,390 291,500
Long‑term Investments 225,000 190,000
Net Property & Equipment 457,000 380,000
Total Assets 1,020,390 861,500
Liabilities & Net Assets FY2024 ($000s) FY2023 ($000s)
Accounts Payable 117,000 97,000
Accrued Expenses 72,000 62,000
Notes Payable (Current) 38,500 32,500
Total Current Liabilities 227,500 191,500
Long‑term Debt 415,000 325,000
Total Liabilities 642,500 516,500
Net Assets 377,890 345,000
Total Liabilities & Net Assets 1,020,390 861,500

Assets grew 18% in FY 2024 due to capital additions and investment growth. Long‑term debt increased significantly to fund expansion projects, pushing the leverage ratio higher. Net assets increased modestly, reflecting retained earnings from net income and contributions.

Condensed statement of operations

The statement of operations (income statement) summarizes revenues and expenses during the fiscal year. It reveals whether Laurel Ridge generated a surplus from operations and how non‑operating items affect the bottom line.

Operating Results FY2024 ($000s) FY2023 ($000s)
Net Patient Service Revenue 651,000 615,000
Premium Revenue 76,000 74,000
Other Revenue 67,000 39,000
Total Operating Revenue 794,000 728,000
Salaries, Wages & Benefits 428,000 383,000
Supplies & Drugs 198,000 172,000
Purchased Services & Other 115,000 109,400
Depreciation & Amortization 28,000 22,000
Interest Expense 18,000 16,000
Total Operating Expenses 787,000 702,400
Operating Income 7,000 25,600
Non‑Operating Contributions & Investment Income 25,490 26,980
Net Income (Excess Revenue over Expenses) 32,490 52,580

Operating revenue grew 9% in FY 2024 but expenses rose 12%, compressing the operating margin to 0.9% on a full accrual basis. A strong investment portfolio and modest contributions lifted the overall net margin to 4.1% (rounded), though still slightly below peer medians. Note how the mix of revenues (patient, premium, other) and the cost structure drive operating results.

Condensed statement of cash flows

Cash flow information illuminates how Laurel Ridge funds its operations, investments and financing activities. The summary below highlights major cash inflows and outflows during FY 2024.

Cash Flows FY2024 ($000s)
Net Cash from Operating Activities 25,250
Net Cash Used in Investing Activities (109,760)
Net Cash from Financing Activities 96,650
Net Increase in Cash & Equivalents 12,140

Operating activities generated positive cash despite reduced net income, reflecting depreciation and working capital adjustments. Significant capital expenditures and investment purchases drove negative investing cash flow, while debt issuance and a bank loan provided strong financing inflows. The result was a modest increase in cash of $12.14 million, keeping liquidity stable.

Narrative & analysis

The FY 2024 financials present a nuanced picture of a growing nonprofit health system balancing mission and margin. Revenue increases were offset by wage inflation, supply costs and interest expense, compressing the operating margin. Investment gains and donations remain crucial to achieving a positive bottom line. The system’s leverage has increased to fund expansion, evidenced by a higher debt‑to‑equity ratio and more long‑term debt on the balance sheet. Days cash on hand improved modestly but remains below industry medians, highlighting the importance of disciplined liquidity management.

Use this information as a springboard for analysis. What happens if payer mix shifts further toward Medicaid? How would a downturn in investment markets affect net income and liquidity? How much debt capacity remains for future projects? These questions and more are explored throughout the Laurel Ridge case.

For the full audited statements, notes and supplemental graphs, download the FY 2024 Annual Financial Report included with the case materials.